Liane Schmal
Schizophrenia is a complex and debilitating psychiatric disorder characterized by disturbances in thinking, perception, emotions and behavior. Pharmacotherapy remains a cornerstone in the management of schizophrenia, aimed at alleviating symptoms and improving quality of life. This article explores the global trends in neuropsychopharmacological prescriptions for adults with schizophrenia, examining the evolving landscape of medication choices, usage patterns and emerging therapies.
この記事をシェアする
English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi 